S&P 500
(0.09%) 5 308.13 points
Dow Jones
(-0.49%) 39 807 points
Nasdaq
(0.65%) 16 795 points
Oil
(-0.19%) $79.65
Gas
(-0.33%) $2.74
Gold
(-0.28%) $2 431.60
Silver
(-1.07%) $32.08
Platinum
(-0.30%) $1 060.50
USD/EUR
(0.13%) $0.921
USD/NOK
(0.25%) $10.70
USD/GBP
(-0.02%) $0.787
USD/RUB
(-0.31%) $90.69

Aktualne aktualizacje dla Gritstone Oncology Inc [GRTS]

Giełda: NASDAQ Sektor: Healthcare Branża: Biotechnology
BUY
100.00%
return 8.34%
SELL
28.57%
return 10.83%
Ostatnio aktualizowano20 geg. 2024 @ 23:00

3.87% $ 0.818

KUPNO 138443 min ago

@ $2.18

Wydano: 14 vas. 2024 @ 21:06


Zwrot: -62.40%


Poprzedni sygnał: vas. 13 - 22:42


Poprzedni sygnał: Sprzedaż


Zwrot: 3.82 %

Live Chart Being Loaded With Signals

Commentary (20 geg. 2024 @ 23:00):
Profile picture for Gritstone Oncology Inc

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases...

Stats
Dzisiejszy wolumen 2.24M
Średni wolumen 2.98M
Kapitalizacja rynkowa 88.80M
EPS $0 ( 2024-05-09 )
Następna data zysków ( $-0.320 ) 2024-06-17
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.660
ATR14 $0.00400 (0.49%)
Insider Trading
Date Person Action Amount type
2024-05-15 Allen Andrew R Buy 47 873 Common Stock
2024-05-16 Allen Andrew R Sell 24 263 Common Stock
2024-05-15 Allen Andrew R Buy 615 000 Stock Option (Right to Buy)
2024-05-15 Jones Erin Buy 27 128 Common Stock
2024-05-16 Jones Erin Sell 13 749 Common Stock
INSIDER POWER
96.52
Last 98 transactions
Buy: 7 577 348 | Sell: 147 493

Wolumen Korelacja

Długi: 0.21 (neutral)
Krótki: -0.99 (very strong negative)
Signal:(45.278) Neutral

Gritstone Oncology Inc Korelacja

10 Najbardziej pozytywne korelacje
LULU0.893
EZGO0.89
ATNF0.887
AFYA0.87
SRNE0.863
QH0.862
ISSC0.861
RCMT0.856
ATRC0.855
YI0.854
10 Najbardziej negatywne korelacje
LABP-0.936
NVEI-0.921
CURI-0.918
CENX-0.918
IDN-0.916
TH-0.909
PAYS-0.908
VFF-0.898
WIRE-0.898
STOK-0.893

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Gritstone Oncology Inc Korelacja - Waluta/Towar

The country flag -0.07
( neutral )
The country flag 0.31
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.21
( neutral )

Gritstone Oncology Inc Finanse

Annual 2023
Przychody: $1.33M
Zysk brutto: $-6.26M (-470.32 %)
EPS: $-1.200
FY 2023
Przychody: $1.33M
Zysk brutto: $-6.26M (-470.32 %)
EPS: $-1.200
FY 2022
Przychody: $9.27M
Zysk brutto: $-6.42M (-69.28 %)
EPS: $-1.240
FY 2021
Przychody: $48.21M
Zysk brutto: $48.21M (100.00 %)
EPS: $-0.965

Financial Reports:

No articles found.

Gritstone Oncology Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Gritstone Oncology Inc

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors comprising metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and shared neoantigen-positive tumors. In addition, it develops CORAL, a SARS-CoV-2 vaccine platform designed to deliver spike and additional SARS-CoV-2 T cell epitopes for protection and broader immunity against SARS-CoV-2 variants; and a therapeutic vaccine candidate designed to treat and cure human immunodeficiency virus (HIV) infection. It has a strategic collaboration with bluebird bio, Inc.; collaboration agreement with Gilead Sciences, Inc.; and license agreement with Genevant Sciences GmbH. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej